Journal profile · Hematology
Current Opinion in Hematology
ISSN 1065-6251 · eISSN 1531-7048 · Lippincott Williams and Wilkins Ltd. · UNITED STATES · Bimonthly
Current Opinion in Hematology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 2.88; JCR Q2 (journal website); hybrid open access; review 6–12 weeks (community reports); community-reported acceptance: moderate; 45 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Current Opinion in Hematology is published by Lippincott Williams and Wilkins Ltd. and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research and Platelet Disorders and Treatments, together about 30.3% of its articles. Its main subfields are Hematology and Genetics. (generated from OpenAlex topic counts and CAS ranking data)
Current Opinion in Hematology is an easy-to-digest bimonthly journal covering the most interesting and important advances in the field of hematology. Its hand-picked selection of editors ensure the highest quality selection of unbiased review articles on themes from nine key subject areas, including myeloid biology, Vascular biology, hematopoiesis and erythroid system and its diseases.
Source: LetPub
Research area (LetPub): Hematology
Editor-in-chief Maha OthmanPublisher website
Main research topics OpenAlex counts of recent articles; shares are approximate
- Hematopoietic Stem Cell TransplantationMedicine11.6%
- Acute Myeloid Leukemia ResearchMedicine11.1%
- Platelet Disorders and TreatmentsMedicine7.6%
- Erythrocyte Function and PathophysiologyMedicine5.5%
- Hemoglobinopathies and Related DisordersMedicine5.2%
- Blood groups and transfusionMedicine5.1%
- Chronic Myeloid Leukemia TreatmentsMedicine4.6%
- Myeloproliferative Neoplasms: Diagnosis and TreatmentMedicine4.6%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Hematology | Zone 4 |
Top journal: noReview journal: yes
JCR / CiteScore quartiles on the journal's website
- JCR Q2 · HEMATOLOGY · rank 41/103
Publisher-reported: JCR figures are Clarivate's and CiteScore figures Scopus's to confirm; both are a different system from the CAS zones.Publisher website
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 2.88LetPub ·
- Impact factor (publisher)
- 2.9Publisher website ·
- CiteScore 2026-06
- 5.4LetPub ·
- SJR 2026-06
- 1.17LetPub ·
- SNIP 2026-06
- 0.86LetPub ·
- h-index
- 90LetPub ·
- h-index
- 127OpenAlex ·
- i10-index
- 1,592OpenAlex ·
- 2-year mean citedness
- 3.44OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 12.93%LetPub ·
Volume
- Articles per year
- 43LetPub ·
Articles by year OpenAlex count · 2,355 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 42 | 11 | 5 |
| 2025 | 45 | 15 | 92 |
| 2024 | 51 | 23 | 378 |
| 2023 | 40 | 18 | 324 |
| 2022 | 47 | 22 | 460 |
| 2021 | 61 | 30 | 960 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
- Average review time (community reports)
- 6–12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
No source has fee information yet; check the journal's website.
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Profile
Publication details and official links
- Publisher
- Lippincott Williams and Wilkins Ltd.
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Bimonthly
- ISSN
- 1065-6251
- Electronic ISSN
- 1531-7048
- Latest issue on the website
- Volume 33, Issue 5 (September 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Current Opinion in Hematology
What CAS zone is Current Opinion in Hematology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Current Opinion in Hematology is in Zone 4 of Medicine, and in Zone 3 of the minor category Hematology. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Current Opinion in Hematology?
The latest impact factor listed by LetPub is 2.88; CiteScore 5.4, h-index 127.
How long does peer review take at Current Opinion in Hematology?
Authors report an average review time of 6–12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What JCR quartile is Current Opinion in Hematology in?
The journal's website gives JCR Q2; by category, HEMATOLOGY Q2 (41/103). JCR quartiles are Clarivate's to confirm and a different system from the CAS zones; in the CAS ranking the journal is in Zone 4 of Medicine.
Which databases index Current Opinion in Hematology?
According to LetPub and DOAJ records, Current Opinion in Hematology is indexed in SCIE and Scopus.
Is Current Opinion in Hematology open access, and what is the APC?
Current Opinion in Hematology is a hybrid journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .